The Process of New Drug Discovery and Development

Author:   Charles G. Smith (Consultant, Rancho Santa Fe, California, USA) ,  James T. O'Donnell (Rush University Medical Center, Chicago, Illinois, USA)
Publisher:   Taylor & Francis Inc
Edition:   2nd New edition
ISBN:  

9780849327797


Pages:   688
Publication Date:   23 June 2006
Replaced By:   9781138080263
Format:   Hardback
Availability:   Out of stock   Availability explained


Our Price $607.20 Quantity:  
Add to Cart

Share |

The Process of New Drug Discovery and Development


Overview

Full Product Details

Author:   Charles G. Smith (Consultant, Rancho Santa Fe, California, USA) ,  James T. O'Donnell (Rush University Medical Center, Chicago, Illinois, USA)
Publisher:   Taylor & Francis Inc
Imprint:   Informa Healthcare
Edition:   2nd New edition
Dimensions:   Width: 17.80cm , Height: 3.60cm , Length: 25.40cm
Weight:   1.338kg
ISBN:  

9780849327797


ISBN 10:   0849327792
Pages:   688
Publication Date:   23 June 2006
Audience:   Professional and scholarly ,  Professional & Vocational
Replaced By:   9781138080263
Format:   Hardback
Publisher's Status:   Out of Stock Indefinitely
Availability:   Out of stock   Availability explained

Table of Contents

General Overview. Integrated Product Development: From Lead Candidate Selection to Life-Cycle Management. Scientific Discoveries Application in New Drug Development. Combinatorial Chemistry. High-Throughput Screening: Enabling and Influencing the Process of Drug Discovery. Pharmacological and Pharmaceutical Profiling: New Trends. Cell-Based Analysis of Drug Response Using Moving Optical Gradient Fields. Patient-Derived Primary Cells in High-Throughput Differential Anti-Tumor Screens: Let the Patients Be the Guide. The Evolving Role of the Caco-2 Cell Model to Estimate Intestinal Absorption Potential and Elucidate Transport Mechanisms. The Promise of Metabonomics in Drug Discovery. Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA-PWG-PhRMA-DruSafe Workshop. Drugs from Molecular Targets for CNS and Neurodegenerative Diseases. Safety Pharmacology. Nonclinical Drug Safety Assessment. Preclinical Genotoxicity Testing-Past, Present and Future. Standard Drug Developmental Issues: Updated. The Need for Animals in Biomedical Research. Defining the Actual Research Approach to the New Drug Substance. Pharmaceutics and Compounding Issues in New Drug Development and Marketing. Late Stage and Process Development Activities. Clinical Development. Contract Research Organizations: Role and Function in New Drug Development. The Front Lines of Clinical Research: The Industry. Horizons for Cancer Chemotherapy (and non-Chemotherapy). Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) Clinical Testing Challenges. Regulatory and Legal Issues Affecting Drug Development. CTD: The Changing Face of the NDA. Electronic Publishing. The Important Role of Pharmacists in a Complex Risk Management System: Managing the Risks from Medical Product Use by Focusing on Patient Education, Monitoring, and Adverse Event Reporting. Liability, Litigation, and Lessons in New Drug Development. Problems in the Non-Drug Marketplace. Patents and New Product Development in the Pharmaceutical and Biotechnology Industries. The Pharmaceutical Revolution: Drug Discovery and Development. Case Histories. The Discovery of Rituxan. Funding the Birth of a Drug: Lessons from the Sell Side. Innovations for the Drug Development Pathway: What Is Needed Now.

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List